Stock listing

Crinetics Pharmaceuticals, Inc.

Selected listing: A2JQTJ · LS · EUR · DE

Crinetics Pharmaceuticals, Inc. (Lang & Schwarz: A2JQTJ), Health Technology. Latest release Aug 3, 2026: Crinetics Pharmaceuticals Reports Second Quarter 2026…

A2JQTJ:LSEURDEUpdated August 31, 2026

Ticker: Lang & Schwarz: A2JQTJ
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Lang & Schwarz
Currency: EUR

Latest news from Crinetics Pharmaceuticals, Inc.

Crinetics Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update

August 3, 2026

Crinetics Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Crinetics Pharmaceuticals, Inc. - CRNX

July 8, 2026

Vertex to Acquire Crinetics Pharmaceuticals

July 5, 2026

Crinetics Presents Long Term Data at ENDO 2026 Confirming PALSONIFY™ (paltusotine) Provides Durable, Consistent Acromegaly Control

June 14, 2026

Crinetics and Leading Patient Groups Launch ‘Everyday Advocacy’ Initiative to Empower People Across Endocrine Disease Communities

June 2, 2026

All Crinetics Pharmaceuticals, Inc. news →

Events

Replays

Crinetics Pharmaceuticals, Inc. (CRNX) Q1 2026 Earnings Call
Thu, May 07, 2026 · 04:30 PM ET
Watch
Crinetics Pharmaceuticals, Inc. (CRNX) Q4 2025 Earnings Call
Thu, Feb 26, 2026 · 04:30 PM ET
Watch
Crinetics Pharmaceuticals, Inc. (CRNX) Q3 2025 Earnings Call
Thu, Nov 06, 2025 · 04:30 PM ET
Watch

Research Crinetics Pharmaceuticals, Inc.

Crinetics Pharmaceuticals, Inc. company profile

View the public company page for Crinetics Pharmaceuticals, Inc. on 6ix.

Crinetics Pharmaceuticals, Inc. news

Read company news and market updates connected to Crinetics Pharmaceuticals, Inc..

Crinetics Pharmaceuticals, Inc. investor events

Find investor webinars, events, and replay context for Crinetics Pharmaceuticals, Inc..